TheEdgeResearch
Home / Stocks / HBMN.SW

HBM Healthcare Investments AG (HBMN.SW)

SIX Financial Services Asset Management
$250.00 ▲ +0.00%
Market Cap
$1.65B
Sector
Financial Services
Industry
Asset Management
Beta
0.76
52-Wk Range
169.4-258
CEO
Andreas Wicki
Country
CH
Currency
CHF

HBM Healthcare Investments AG operates in the Asset Management industry of the Financial Services sector, headquartered in Zug, ZG, CH. The stock last traded at $250.00, up 0.00% on the session, giving a market capitalisation of $1.65B. Its beta of 0.76 implies it has historically moved less than the broad market.

Company profile
Exchange
Swiss Exchange
Employees
IPO date
2008-02-14
Headquarters
Zug, ZG, CH
About HBM Healthcare Investments AG

HBM Healthcare Investments AG specializes in both direct investments and a fund-of-funds strategy, focusing exclusively on the healthcare sector, encompassing human medicine, pharmaceuticals, biotechnology, diagnostics, and medical technology. Its direct investments target a diverse range of companies, from early-stage startups and various venture and growth phases to mature private enterprises, unlisted emerging firms, and small-cap public entities. The firm also provides capital for company buyouts, growth initiatives, Private Investments in Public Equity (PIPEs), and the spin-off of product lines or departments from larger corporations, as well as the expansion or restructuring of established businesses. Through its fund-of-funds approach, HBM allocates capital to venture capital funds. Initial direct investments are typically made in companies whose primary products are either in clinical development or just prior to that stage. With a global investment mandate, the company emphasizes opportunities in North America, Europe, and the Asia Pacific region. For publicly traded companies, HBM generally prioritizes those that originated within its private investment portfolio. The firm often increases its commitment to portfolio companies through subsequent financing rounds or after their initial public offering. HBM frequently secures a seat on the portfolio company's Board of Directors and may acquire majority stakes. While primarily investing through equity, it also employs various other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. Exits from these investments are typically facilitated through trade sales or initial public offerings.

Comparable companies

HBM Healthcare Investments AG is most often compared with the following Financial Services names:

BCGE.SWCPEN.SWGAM.SWGRKP.SWPEHN.SWTKBP.SWVAHN.SWVATN.SWVPBN.SWWKBN.SW
More research on HBMN.SW
HBMN.SW technical analysis HBMN.SW TheEdge Score Compare against peers
Open full interactive analysis & DCF →